Skip to main navigation Skip to search Skip to main content

Biallelic DMXL2 mutations impair autophagy and cause Ohtahara syndrome with progressive course

  • Alessandro Esposito
  • , Antonio Falace
  • , Matias Wagner
  • , Moran Gal
  • , Davide Mei
  • , Valerio Conti
  • , Tiziana Pisano
  • , Davide Aprile
  • , Maria Sabina Cerullo
  • , Antonio De Fusco
  • , Silvia Giovedì
  • , Annette Seibt
  • , Daniella Magen
  • , Tilman Polster
  • , Ayelet Eran
  • , Sarah L. Stenton
  • , Chiara Fiorillo
  • , Sarit Ravid
  • , Ertan Mayatepek
  • , Hava Hafner
  • Saskia Wortmann, Erez Y. Levanon, Carla Marini, Hanna Mandel, Fabio Benfenati, Felix Distelmaier, Anna Fassio, Renzo Guerrini
  • Italian Institute of Technology
  • University of Genoa
  • University of Florence
  • Technical University of Munich
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Heinrich Heine University Düsseldorf
  • Technion-Israel Institute of Technology
  • Pediatric Nephrology Institute
  • Epilepsy Center Bethel
  • IRCCS Istituto Giannina Gaslini - Genova
  • Rambam Health Care Campus Israel
  • Neurosurgery laboratory
  • Paracelsus Private Medical University
  • Rambam Health Care Campus
  • San Martino Hospital Genoa
  • IRCCS Fondazione Stella Maris - Calambrone (Pisa)

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Ohtahara syndrome, early infantile epileptic encephalopathy with a suppression burst EEG pattern, is an aetiologically heterogeneous condition starting in the first weeks or months of life with intractable seizures and profound developmental disability. Using whole exome sequencing, we identified biallelic DMXL2 mutations in three sibling pairs with Ohtahara syndrome, belonging to three unrelated families. Siblings in Family 1 were compound heterozygous for the c.5135C4T (p.Ala1712Val) missense substitution and the c.4478C4G (p.Ser1493*) nonsense substitution; in Family 2 were homozygous for the c.4478C4A (p.Ser1493*) nonsense substitution and in Family 3 were homozygous for the c.7518-1G4A (p.Trp2507Argfs*4) substitution. The severe developmental and epileptic encephalopathy manifested from the first day of life and was associated with deafness, mild peripheral polyneuropathy and dysmorphic features. Early brain MRI investigations in the first months of life revealed thin corpus callosum with brain hypomyelination in all. Follow-up MRI scans in three patients revealed progressive moderate brain shrinkage with leukoencephalopathy. Five patients died within the first 9 years of life and none achieved developmental, communicative or motor skills following birth. These clinical findings are consistent with a developmental brain disorder that begins in the prenatal brain, prevents neural connections from reaching the expected stages at birth, and follows a progressive course. DMXL2 is highly expressed in the brain and at synaptic terminals, regulates v-ATPase assembly and activity and participates in intracellular signalling pathways; however, its functional role is far from complete elucidation. Expression analysis in patient-derived skin fibroblasts demonstrated absence of the DMXL2 protein, revealing a loss of function phenotype. Patients’ fibroblasts also exhibited an increased LysoTrackerÕ signal associated with decreased endolysosomal markers and degradative processes. Defective endolysosomal homeostasis was accompanied by impaired autophagy, revealed by lower LC3II signal, accumulation of polyubiquitinated proteins, and autophagy receptor p62, with morphological alterations of the autolysosomal structures on electron microscopy. Altered lysosomal homeostasis and defective autophagy were recapitulated in Dmxl2-silenced mouse hippocampal neurons, which exhibited impaired neurite elongation and synaptic loss. Impaired lysosomal function and autophagy caused by biallelic DMXL2 mutations affect neuronal development and synapse formation and result in Ohtahara syndrome with profound developmental impairment and reduced life expectancy.

Original languageEnglish
Pages (from-to)3876-3891
Number of pages16
JournalBrain
Volume142
Issue number12
Early online date5 Nov 2019
DOIs
StatePublished - 1 Dec 2019

Bibliographical note

Publisher Copyright:
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.

Funding

This study was supported by grants from the European Commission (Seventh Framework Programme FP7 under the project DESIRE grant agreement n° 602531), the German Research Foundation/Deutsche Forschungsgemeinschaft (DI 1731/2-1 to F.D.), and the “Elterninitiative Kinderkrebsklinik e.V.” (Düsseldorf; #701900167).

FundersFunder number
German Research Foundation/Deutsche ForschungsgemeinschaftDI 1731/2-1, 701900167
European Commission
Seventh Framework Programme602531

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Autophagy
    • Developmental and epileptic encephalopathy
    • Neuropathy
    • Ohtahara syndrome
    • Progressive disorder

    Fingerprint

    Dive into the research topics of 'Biallelic DMXL2 mutations impair autophagy and cause Ohtahara syndrome with progressive course'. Together they form a unique fingerprint.

    Cite this